Authors
Sijun Zhang, Yinlan Wu, Yanhong Li, Xing Ji, Yuxia Huang, Wanrong Liu, Chunyu Tan, Yubin Luo
Published in
Clinical and experimental rheumatology. Nov 05, 2026. Epub Nov 05, 2026.
Abstract
Systemic sclerosis-associated interstitial lung disease (SSc-ILD) is a major driver of mortality in systemic sclerosis and a prototypical fibroinflammatory disorder in which pulmonary fibrosis unfolds alongside systemic immune, vascular and extrapulmonary abnormalities. Animal models remain essential for mechanistic interrogation and preclinical testing, yet most capture only selected facets of the disease and fall short of the integrated human phenotype.Here, we critically examine established SSc-ILD models through the lens of translational fidelity. Across bleomycinbased, chemical, genetic and immunemediated platforms, striking differences emerge in disease spectrum, reproducibility and biological relevance, and few models recapitulate the integrated fibroinflammatory, immune and vascular complexity of human SSc-ILD.This unresolved gap continues to constrain mechanistic insight and therapeutic development. Advancing the field will require next-generation models that more closely reflect the complexity, chronicity and heterogeneity of human SSc-ILD.
PMID:
43001850
Bibliographic data and abstract were imported from PubMed on 09 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0